Back to search

Article

Differences in clinical features, disease outcomes and imaging features of demyelinating syndrome after MOG antibody therapy

2023-03-31

Abstract excerpt

<title>Abstract</title><p>Objective: To strengthen the clinicians' understanding of the clinical characteristics of patients with negative MOGADD antibody. <h4>Methods:</h4> The clinical data of 23 MOGADD patients with antibody negative conversion who were hospitalized in the Department of Neurology, the First Affiliated Hospital of China Medical University in Shenyang, Liaoning Province from March 2020 to August...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d66e0d4-3ba7-5ed3-9317-de727481dc2a
DOI
10.21203/rs.3.rs-2706823/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Differences in clinical features, disease outcomes and imaging features of demyelinating syndrome after MOG antibody therapyDOI 10.21203/rs.3.rs-2706823/v1
Select a neighboring publication to make it the new centre.